BIT 0.00% 3.3¢ biotron limited

Ann: Significant Immunological Outcomes in BIT225 HIV-1 Trial, page-136

  1. 1,081 Posts.
    lightbulb Created with Sketch. 375
    Only minor R&D rebate which is due in this quarter and generally between 1.2m-1.6m

    Options are looking strong for conversation, time will tell by end of the week. Strong finish again this afternoon.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.